The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for D Scott


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor.EBI
Pfizer
Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids.EBI
Texas Biotechnology
Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs.EBI
Biogen Idec
Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.EBI
Alcon Research
Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model.EBI
Amgen
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitors.EBI
Biogen
Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens.EBI
Biogen
Covalent Guanosine Mimetic Inhibitors of G12C KRAS.EBI
Dana Farber Cancer Institute
NOVEL RAPAMYCIN DERIVATIVESBDB
Novartis
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139BDB
Takeda Pharmaceutical
Design, synthesis, and anticonvulsant activity of some derivatives of xanthone with aminoalkanol moieties.BDB
Jagiellonian University Medical College
HIV protease inhibitorsBDB
Merck Canada